Max Hodak

Max Hodak, co-founder of Neuralink and founder of Science Corp, dives into the futuristic realm of brain-computer interfaces. He discusses exciting advancements in retinal prosthetics to restore vision and the market potential of these innovations. Max emphasizes the urgent need for sustainable investment in BCI technology and how vertical integration can help. The conversation also explores neuronal growth, human enhancement technologies, and the groundbreaking possibilities of merging AI with human intelligence, hinting at a new era of consciousness.

Spencer Peterson, a general partner at Coatue Ventures, discusses the booming AI developer tools market and highlights the rapid growth of Cursor. Max Hodak, CEO of Science Corporation, shares breakthroughs in retinal prostheses and brain-machine interfaces. Andrew Dudum, founder of Hims & Hers, details innovations in digital health and personalized care. Meanwhile, Melisa Tokmak introduces Netic's AI solutions for essential services, while Tomás Puig reveals Alembic's causal AI strategies for marketing impact. Jeffrey Katzenberg rounds out the discussion with insights on fundraising.

Max Hodak, founder of Science Corp and former president of Neuralink, dives into the fascinating world of brain-computer interfaces. He discusses the complexities of understanding the brain's 86 billion neurons and the revolutionary potential of technology to restore vision and mobility. The conversation explores ethical considerations of connecting multiple brains, the societal implications of integrating consciousness with technology, and the future of human capabilities through bioengineering. It's a thought-provoking look at the intersection of neuroscience and innovation.